LIANBIO-ADR (LIAN) Stock Balance Sheet
NASDAQ:LIAN - Nasdaq - US53000N1081 - ADR - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 103.50M | 79.20M | 228.20M | 254.40M | 43.30M | |||
| Marketable Securities | 148.80M | 223.10M | 155.10M | N/A | N/A | |||
| Receivables | 1.80M | 4.40M | 7.20M | 21.30M | 0.00 | |||
| Other Current Assets | 3.80M | 6.00M | 9.20M | 1.10M | 0.00 | |||
| Total Current Assets | 257.80M | 312.80M | 399.60M | 276.70M | 43.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.00M | 7.10M | 6.60M | 2.50M | 500.00K | |||
| Other Non-Current Assets | 100.00K | 100.00K | 20.10M | 0.00 | 0.00 | |||
| Total Non-Current Assets | 5.10M | 7.20M | 26.70M | 2.60M | 600.00K | |||
| TOTAL ASSETS | 262.90M | 320.00M | 426.30M | 279.30M | 43.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.80M | 21.70M | 11.10M | 1.50M | 500.00K | |||
| Accounts Payable | 6.20M | 1.50M | 3.20M | 4.30M | 0.00 | |||
| Other Current Liabilities | 1.60M | 500.00K | 800.00K | 400.00K | 2.80M | |||
| Total Current Liabilities | 25.60M | 23.60M | 15.10M | 6.20M | 3.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.20M | 2.70M | 23.90M | 21.30M | 400.00K | |||
| Total Non-Current Liabilities | 35.00M | 36.50M | 57.70M | 56.10M | 1.40M | |||
| TOTAL LIABILITIES | 60.60M | 60.10M | 72.80M | 62.30M | 4.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -540.20M | -470.50M | -360.20M | -163.90M | -24.30M | |||
| Additional Paid In Capital | 745.80M | 732.50M | 713.30M | 31.10M | 8.50M | |||
| Minority Interest | 33.80M | 33.80M | 33.80M | 34.80M | 1.00M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 349.80M | 55.00M | |||
| Other Shareholders' Equity | -3.20M | -2.10M | 500.00K | 0.00 | 0.00 | |||
| Shares Outstanding | N/A | 107.00M | 107.30M | 105.30M | 105.30M | |||
| Tangible Book Value per Share | N/A | 2.43 | 3.30 | -1.26 | -0.15 | |||
| Total Shareholders' Equity | 202.30M | 259.90M | 353.60M | 216.90M | 39.20M | |||
| TOTAL LIABILITIES AND EQUITY | 262.90M | 320.00M | 426.30M | 279.30M | 43.90M | |||
| Statistics | ||||||||
| Current Ratio | 10.07 | 13.25 | 26.46 | 44.63 | 13.12 | |||
| Return On Assets (ROA) | -33.47% | -34.47% | -46.05% | -49.98% | -55.42% | |||
| Return On Equity (ROE) | -43.49% | -42.44% | -55.51% | -64.36% | -62.07% | |||
All data in USD , ROIC based on taxRate of 0.21